JPMorgan Chase & Co. (JPM) 13D/13G Filings for TherapeuticsMD, Inc. (TXMD)

JPMorgan Chase & Co. 13D and 13G filings for TherapeuticsMD, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2020-12-09
11:54 am
Sale
2020-11-3013GTherapeuticsMD, Inc.
TXMD
JPMORGAN CHASE & CO
JPM
261,589
4.300%
-132,772decrease
(-33.67%)
Filing